ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

ClinicalTrials.gov ID: NCT02625610

Public ClinicalTrials.gov record NCT02625610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 8:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction

Study identification

NCT ID
NCT02625610
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
EMD Serono Research & Development Institute, Inc.
Industry
Enrollment
499 participants

Conditions and interventions

Interventions

  • 5-Fluorouracil Drug
  • Avelumab Drug
  • Best supportive care Other
  • Capecitabine Drug
  • Leucovorin Drug
  • Oxaliplatin Drug

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 23, 2015
Primary completion
Sep 12, 2019
Completion
Jun 2, 2021
Last update posted
Jun 8, 2022

2015 – 2021

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
34
Facility City State ZIP Site status
Comprehensive Blood & Cancer Center Bakersfield California 93309
Virginia Crosson Cancer Center Fullerton California 92835
UCLA Medical Center Los Angeles California 90095
Desert Hematology Oncology Medical Group, Inc. Rancho Mirage California 92262
Sansum Clinic Santa Barbara California 93105
Trio - Central Coast Medical Oncology Corporation Santa Maria California 93454
Norwalk Hospital Norwalk Connecticut 6856
UF Health Cancer Center Orlando Orlando Florida 32806
Memorial West Cancer Institute Pembroke Pines Florida 33028
University of South Florida - Parent Tampa Florida 33606
Oncology Specialists, S.C. Park Ridge Illinois 60068
Franciscan St. Francis Health Cancer Center Indianapolis Indiana 46237
Cedar Rapids Oncology Project Cedar Rapids Iowa 52403
Cotton-O'Neil Clinical Research Center, Hematology and Oncology Topeka Kansas 66604
University of Kansas Medical Center Research Institute, Inc. Westwood Kansas 66205
Virginia Piper Cancer Institute Minneapolis Minnesota 55407
Nevada Cancer Research Foundation Las Vegas Nevada 89106
Mount Sinai - PRIME Jamaica New York 11432
Clinical Research Alliance, Inc New York New York 10021
University of Rochester Rochester New York 14642
UC Health Clinical Trials Office Cincinnati Ohio 45206
TriHealth Hatton Institute Cincinnati Ohio 45220
Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center Columbus Ohio 43219
Oregon Health & Science University Portland Oregon 97239
St. Luke's Hospital Bethlehem Pennsylvania 18015
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107
Rhode Island Hospital Providence Rhode Island 02903
Greenville Hospital System University Medical Center (ITOR) Greenville South Carolina 29605
University of Texas Southwestern Medical Center Dallas Texas 75390-9179
Oncology Consultants, P.A. Houston Texas 77024
University of Texas Health Science Center at San Antonio San Antonio Texas 78229
Baylor Scott & White Health Temple Texas 76508
University of Washington - Seattle Cancer Care Alliance East Seattle Washington 98109
Northwest Medical Specialties, PLLC Tacoma Washington 98405
Wenatchee Valley Hospital & Clinics Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 165 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02625610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2022 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02625610 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →